Trial Profile
Study for the Multi-Center Placebo-Controlled Double-Blind Clinical Trial for the Evaluation of the Effect of Cilostazol on Pulsatility Index of Transcranial Doppler in the Acute Lacunar Infarction Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary) ; Aspirin
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacodynamics
- Acronyms ECLIPse
- 01 Feb 2013 Primary endpoint 'Pulsatility-index' has been met.
- 02 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2009 Results have been presented at EFNS 2009.